Visikol CEO Michael Johnson Named to NJBIZ 2021 Next Generation of Leaders
Griffin Ferrara2021-07-16T14:51:43-05:00On Tuesday, Visikol's CEO Michael Johnson was named to the 2021 Next Generation of Leaders List by NJBIZ. The [...]
Visikol partners with MatTek to leverage their advanced cell culture models in its suite of drug discovery services
Griffin Ferrara2021-07-06T08:43:24-05:00TUE, JUL 06, 2021 15:00 CET Over the last two months, both MatTek and Visikol have been acquired by [...]
Visikol expands its Hampton, NJ Facility
Griffin Ferrara2021-06-29T10:19:42-05:00Visikol has announced today another expansion of its Hampton, NJ facility. Through the expansion, Visikol has grown its lab [...]
Visikol Joins CELLINK
Griffin Ferrara2021-05-21T08:39:40-05:00May 20th, 2021 - Today Visikol joins the CELLINK family through acquisition. The acquisition provides CELLINK the opportunity to [...]
Visikol Awarded $1.64M NIH NCI Phase II SBIR Award to Further Develop Imaging and Digital Pathology Portfolio
Mike Johnson2021-05-02T06:17:06-05:00Over the last five years, Visikol has developed an extensive portfolio of advanced imaging, digital pathology and cell culture [...]
Visikol Launches BitSlide, Cloud-Based Digital Pathology Slide Visualization Platform
Griffin Ferrara2021-02-09T14:40:29-05:00Visikol has been a leader in advanced bioimaging through its portfolio of cutting-edge technologies and innovative drug discovery, bioimaging, [...]
Visikol Expands Hampton Facility to Accommodate Service Growth
Griffin Ferrara2021-01-18T10:32:43-05:002020 was a challenging year for all industries and the life sciences field was no exception. Throughout 2020, Visikol [...]
Visikol uses Multiplex Imaging Tools in Partnership with Hackensack Meridian Health
Griffin Ferrara2020-12-08T10:03:38-05:00Tuberculosis (TB) is still one of the top ten leading causes of death globally. Although TB is both preventable [...]
Visikol Launches Multiplex Slide Imaging and Analysis Services
Griffin Ferrara2020-12-02T12:42:10-05:00The Visikol research team has developed a novel tissue multiplexing approach which leverages a proprietary antibody stripping reagent combined [...]
Visikol Becomes VIP Supplier on Scientist.com Marketplace
Mike Johnson2020-11-05T10:48:01-05:00Visikol, a leading drug discovery company focused on advanced imaging, digital pathology and 3D cell culture assays, announced today [...]